Amgen (Q14171): Difference between revisions
Jump to navigation
Jump to search
Created claim: stock exchange (P574): Nasdaq (Q8874) |
Added link to [en]: Amgen |
||
| (5 intermediate revisions by the same user not shown) | |||
| Property / stock exchange | |||
| Property / stock exchange: Hong Kong Exchanges And Clearing Ltd / rank | |||
Normal rank | |||
| Property / stock exchange: Hong Kong Exchanges And Clearing Ltd / qualifier | |||
ticker symbol: 4332 | |||
| Property / product or material produced or service provided | |||
| Property / product or material produced or service provided: erenumab / rank | |||
Normal rank | |||
| Property / official website | |||
| Property / official website: http://www.amgen.com/ / rank | |||
Normal rank | |||
| Property / official website: http://www.amgen.com/ / qualifier | |||
| Property / described at URL | |||
| Property / described at URL: http://www.fundinguniverse.com/company-histories/amgen-inc-history/ / rank | |||
Normal rank | |||
| Property / Commons category | |||
Amgen | |||
| Property / Commons category: Amgen / rank | |||
Normal rank | |||
| links / en / name | links / en / name | ||
Latest revision as of 09:35, 16 August 2023
American multinational biopharmaceutical company
- Applied Molecular Genetics
- Amgen Inc.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amgen |
American multinational biopharmaceutical company |
|
Statements
1980
0 references
Amgen
0 references